Cannabis-derived treatment eases agitation in hospice-eligible dement… | HappeningNow.news
Published Date: July 14, 2026

Health · 1 views

Cannabis-derived treatment eases agitation in hospice-eligible dementia patients, trial finds

In a first-of-its-kind clinical trial, U.S.

Source Medical Xpress AI Summary Updated 1h 47m ago
Story intelligence Beta
Freshness Fresh Updated 1h 47m ago
Confidence Limited Single-outlet story
Coverage Single outlet
Views 1 Community interest
Read time 1 min ~41 words

AI Summary

In a first-of-its-kind clinical trial, U.S. researchers found that people with agitation and dementia in late life who took a special medical formulation of two active ingredients found in marijuana—THC and CBD—had significantly less agitation than people who received a placebo.

Read full article on Medicalxpress

AI summaries can be wrong sometimes—always verify important details using the source article.

More coverage on this topic

United States3606 stories
View all United States coverage
SUPPORT HAPPENINGNOW · Independent AI News Intelligence
SUPPORTER MESSAGE

Enjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.

Support HappeningNow

More from Health

Continue reading recent Health coverage